Endometrial Cancer Care RUBY Trial
-
Location
Zoom-US
-
Phone
+966 112790305
- Website: www.credit-hours.com Join Event
- Email Address: info@credit-hours.com
- Email Activity Coordinator: cpd2@credit-hours.com
- Phone Activity Coordinator: +966 598987505
Event Audience
- Nuclear Medicine
- Medical Oncology
- Family Medicine
- General surgery
- Internal Medicine
- Anatomic Pathology
- Emergency Medicine
- Obstetrics and Gynecology
- General Practice
- Clinical Pathology
- Critical Care Medicine
- Radiation Oncology
- Diagnostic Radiology
- Public Health
- Preventive Medicine
- Pathology
- Family and Community Medicine
- Midwifery
- Nursing
- Adult Critical Care Nursing
- Medical and Surgical Nursing
- Primary Health Care Nursing
- Nursing Education
- Maternity and Child Health Nursing
- Oncology and Palliative Care Nursing
- Obstetrics and Gynecologic Nursing
- Emergency Care Nursing
- Community and Public Health Nursing
- Pharmaceutical Sciences
- Clinical Pharmacy
- Pharmaceutical administration AND outcomes
- Pharmacy
Event Goals
- •Explain the latest guidelines for managing advanced and recurrent endometrial cancer (EC) and their application in clinical practice.
- •Describe the integration of new emerging immunological therapeutic agents monotherapy or in combination with other therapeutic agents for the treatment options and management of Endometrial Cancer
- •Interpret the clinical results from key clinical trials such as the RUBY trial, emphasizing their implications for improving progression-free and overall survival in EC management.
- •Compare traditional chemotherapy regimens with combination therapies involving immunotherapy and their effectiveness in different EC patient
Event Agenda
17/04/2025
Welcome and Introduction
20:00:00 - 20:10:00
Speaker(s):
No speakers assigned
17/04/2025
Pre-test to assess the current knowledge
20:15:00 - 20:25:00
Speaker(s):
احمد محمد باذيب (AHMED MOHAMMED BADHEEB)
17/04/2025
Endometrial Cancer Care – RUBY Trial
20:30:00 - 21:00:00
Speaker(s):
احمد محمد باذيب (AHMED MOHAMMED BADHEEB)
17/04/2025
Safety and efficacy of novel therapies for Endometrial Cancer
21:10:00 - 21:40:00
Speaker(s):
احمد محمد باذيب (AHMED MOHAMMED BADHEEB)
17/04/2025
Case-based Discussion and Q/A session
21:50:00 - 22:20:00
Speaker(s):
احمد محمد باذيب (AHMED MOHAMMED BADHEEB)
17/04/2025
Post-Test
22:30:00 - 22:40:00
Speaker(s):
احمد محمد باذيب (AHMED MOHAMMED BADHEEB)
17/04/2025
Take home messages and Closure
22:50:00 - 23:00:00
Speaker(s):
No speakers assigned
© 2024 Marvel Developed by Marvel Development Team